CALA · Calithera Biosciences

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

343 Oyster Point Boulevard, South San Francisco, CA, 94080, United States
Shell Companies
Financial Services

Market Cap

487

52 Wk Range

$0.00 - $0.00

Previous Close

$0.00

Open

$0.00

Volume

201

Day Range

$0.00 - $0.00

Enterprise Value

24.36K

Cash

N/A

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

N/A